Dr. William Figlesthaler, M.D.
What this data tells you about Dr. Figlesthaler
Dr. William Figlesthaler is an urology physician in Naples, FL, with 19 years in practice. Based on federal Medicare data, Dr. Figlesthaler performed 18,583 Medicare services across 8,104 unique beneficiaries.
Between the years covered by Open Payments, Dr. Figlesthaler received a total of $976 from 16 pharmaceutical and/or device companies across 47 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Figlesthaler is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual | 3,949 | $3 | $17 |
| Bladder ultrasound after voiding | 3,019 | $8 | $33 |
| Office visit, established patient (30-39 min) | 2,864 | $96 | $392 |
| BCG treatment for bladder cancer | 2,601 | $2 | $8 |
| Blood draw (venipuncture) | 1,145 | $8 | $24 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 480 | $3 | $12 |
| Simple bladder irrigation and/or instillation | 461 | $31 | $236 |
| Diagnostic exam of bladder and urethra using an endoscope | 448 | $191 | $740 |
| Electronic assessment of bladder emptying | 426 | $6 | $47 |
| Office visit, established patient, complex (40-54 min) | 336 | $140 | $550 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 319 | $137 | $600 |
| New patient office visit, complex (60-74 min) | 301 | $162 | $681 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 223 | $18 | $70 |
| Ceftriaxone antibiotic injection | 216 | $0 | $30 |
| Drug injection, under skin or into muscle | 209 | $11 | $43 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 201 | $27 | $199 |
| Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | 200 | $316 | $1,189 |
| Insertion of device into abdomen with pressure and urine flow rate study | 194 | $157 | $584 |
| Insertion of temporary bladder tube | 112 | $35 | $139 |
| Instillation of anti-cancer drug into bladder | 103 | $69 | $272 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 102 | $609 | $2,291 |
| Ultrasound scan of pelvic region through rectum | 97 | $109 | $610 |
| Office visit, established patient (20-29 min) | 91 | $63 | $281 |
| Dilation of urethra using an endoscope | 88 | $255 | $1,002 |
| Simple insertion of temporary bladder tube | 67 | $48 | $190 |
| Simple change of bladder tube | 60 | $78 | $302 |
| Tissue marker, implantable, any type, each | 59 | $107 | $165 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 54 | $26 | $103 |
| Injection of biodegradable material next to prostate | 34 | $2,357 | $8,752 |
| Placement of device in prostate for radiation therapy | 29 | $63 | $470 |
| Biopsy of prostate gland | 23 | $201 | $749 |
| Ultrasonic guidance for needle placement | 23 | $46 | $179 |
| Insertion of stent in ureter using an endoscope | 19 | $122 | $640 |
| Injection procedure to cause erection | 19 | $72 | $283 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 11 | $266 | $986 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
5.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Figlesthaler is a clinical cardiology specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Figlesthaler experienced with urinalysis, manual?
Does Dr. Figlesthaler receive payments from pharmaceutical companies?
How do Dr. Figlesthaler's costs compare to other urology physicians in Naples?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology